PCLLA-nanoHA Bone Substitute Promotes M2 Macrophage Polarization and Improves Alveolar Bone Repair in Diabetic Environments
Open Access
- 30 October 2023
- journal article
- research article
- Published by MDPI AG in Journal of Functional Biomaterials
- Vol. 14 (11) , 536
Abstract
The utilization of bioresorbable synthetic bone substitutes with immunomodulatory properties has gained significant attention in dental clinical applications for the absorption of alveolar bone induced by orthodontic treatment. In this study, we developed two distinct materials: a conventional hydroxyapatite (HA) bone powder comprised of hydroxyapatite particles and nanoHA embedded within a poly(caprolactone-co-lactide) (PCLLA) elastomeric matrix. We assessed the physicochemical characteristics of the bone substitute, specifically focusing on its composition and the controlled release of ions. Our findings show that PCLLA-nanoHA has deformable properties under 40 N, and a significant release of Ca and P elements was noted after 7 days in aqueous settings. Moreover, at the protein and gene expression levels, PCLLA-nanoHA enhances the capacity of macrophages to polarize towards an M2 phenotype in vitro. In vivo, PCLLA-nanoHA exhibits comparable effects to standard HA bone powder in terms of promoting alveolar bone regeneration. Extensive investigations reveal that PCLLA-nanoHA surpasses the commonly employed HA bone powder in stimulating bone tissue repair in diabetic mice. We have identified that PCLLA-nanoHA regulates macrophage M2 polarization by activating the PI3K/AKT and peroxisome proliferator-activated receptor gamma (PPAR) signaling pathways, thereby facilitating a favorable local immune microenvironment conducive to bone repair and regeneration. Our findings suggest that PCLLA-nanoHA presents itself as a promising bioresorbable bone substitute with properties that promote macrophage M2 polarization, particularly in the context of regulating the local microenvironment of alveolar bone in diabetic mice, potentially facilitating bone tissue regeneration.Keywords
Funding Information
- National Natural Science Foundation of China (82101067, 2022M720290)
- China Postdoctoral Science Foundation (82101067, 2022M720290)
This publication has 42 references indexed in Scilit:
- Mesenchymal stem cell-macrophage crosstalk and bone healingBiomaterials, 2019
- Cellular Uptake and Delivery-Dependent Effects of Tb3+-Doped Hydroxyapatite NanorodsMolecules, 2017
- Covalent immobilization of MSC-affinity peptide on poly(L-lactide-co-ε-caprolactone) copolymer to enhance stem cell adhesion and retention for tissue engineering applicationsMacromolecular Research, 2016
- Macrophages in Tissue Repair, Regeneration, and FibrosisImmunity, 2016
- Fate decision of mesenchymal stem cells: adipocytes or osteoblasts?Cell Death & Differentiation, 2016
- Glucagon‐Like Peptide‐1 Formulation – the Present and Future Development in Diabetes TreatmentBasic & Clinical Pharmacology & Toxicology, 2015
- Attenuating Immune Response of Macrophage by Enhancing Hydrophilicity of Ti SurfaceJournal of Nanomaterials, 2015
- Diabetes mellitus and oral healthEndocrine, 2014
- Macrophage Polarization and Insulin Resistance: PPARγ in ControlCell Metabolism, 2007
- Fabrication of microstructures in photosensitive biodegradable polymers for tissue engineering applicationsBiomaterials, 2004